Articles published by 2seventy bio, Inc.
![](https://mms.businesswire.com/media/20240807192042/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
August 07, 2024
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20240805794829/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20240624605310/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20240522999662/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20240508400038/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20240503081790/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20240401936098/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron
April 01, 2024
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20240320941015/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors
March 20, 2024
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20240305186843/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Progress
March 05, 2024
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20240301891782/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20240205638676/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio to Participate in Upcoming Investor Conferences
February 05, 2024
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20240129369390/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Announces New Strategic Path Forward
January 30, 2024
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20231211918212/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20231206910473/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Reiterates Commitment to Maximizing Shareholder Value
December 06, 2023
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20231114877233/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress
November 14, 2023
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20231110054123/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230912518500/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230906610874/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio to Participate in the 2023 Morgan Stanley Global Healthcare Conference
September 06, 2023
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20230814766402/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
August 14, 2023
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20230807521437/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230614964229/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Announces Clinical Study Pause of PLAT-08 Trial of SC-DARIC33 in Acute Myeloid Leukemia
June 14, 2023
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20230607005515/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230517005230/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230511005642/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230503005950/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230428005266/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230316005678/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Progress
March 16, 2023
From 2seventy bio, Inc.
Via Business Wire
Tickers
TSVT
![](https://mms.businesswire.com/media/20230307006081/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230303005100/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230228006498/en/1257457/22/2seventy_logo_for_BW.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.